Economic and health consequences of the TTQ strategy in Spain
| Estimate | Quantity | Unit cost | Total costs |
|---|---|---|---|
| TTQ strategy daily costs | |||
| Tests (unit cost per test) | 187,760 | 40 € | 7,510,400 € |
| Tracers (unit cost per day) | 9,388 | 129 € | 1,206,358 € |
| Health consequences prevented daily | |||
| COVID-19 total cases | 53,286 | ||
| COVID-19 cases treated at home | 48,615 | 280 € | 13,612,174 € |
| Hospitalizations | 2,931 | 8,500 € | 24,911,191 € |
| ICU stays | 213 | 33,400 € | 7,118,703 € |
| Cases suffering long-term morbidity | 1,048 | 14,754 € | 15,461,009 € |
| Deaths | 480 | ||
| QALY gains | |||
| QALY gain from avoided morbidity | 2,908 | ||
| QALY gain from avoided mortality | 1,398 | ||
| Total monetary costs | 8,716,758 € | ||
| Total monetary savings | 61,103,076 € | ||
| Incremental costs | −52,386,318 € | ||
| Incremental QALYs | 4,306 | ||
| Cost per QALY gained | Dominating | ||
| Benefit-to-cost ratio (excluding health and morbidity) | 7.0 | ||
| Benefit-to-cost ratio (including health and morbidity) | 19.4 |
| Estimate | Quantity | Unit cost | Total costs |
|---|---|---|---|
| TTQ strategy daily costs | |||
| Tests (unit cost per test) | 187,760 | 40 € | 7,510,400 € |
| Tracers (unit cost per day) | 9,388 | 129 € | 1,206,358 € |
| Health consequences prevented daily | |||
| COVID-19 total cases | 53,286 | ||
| COVID-19 cases treated at home | 48,615 | 280 € | 13,612,174 € |
| Hospitalizations | 2,931 | 8,500 € | 24,911,191 € |
| ICU stays | 213 | 33,400 € | 7,118,703 € |
| Cases suffering long-term morbidity | 1,048 | 14,754 € | 15,461,009 € |
| Deaths | 480 | ||
| QALY gains | |||
| QALY gain from avoided morbidity | 2,908 | ||
| QALY gain from avoided mortality | 1,398 | ||
| Total monetary costs | 8,716,758 € | ||
| Total monetary savings | 61,103,076 € | ||
| Incremental costs | −52,386,318 € | ||
| Incremental QALYs | 4,306 | ||
| Cost per QALY gained | Dominating | ||
| Benefit-to-cost ratio (excluding health and morbidity) | 7.0 | ||
| Benefit-to-cost ratio (including health and morbidity) | 19.4 |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.